Relmada Therapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell RLMD and other ETFs, options, and stocks.About RLMD
Relmada Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in addressing diseases of the central nervous system. It develops esmethadone, an N-methyl-D-aspartate receptor antagonist for the treatment of CNS diseases, and oral agent for depression and other potential indications.
RLMD Key Statistics
Stock Snapshot
As of today, Relmada Therapeutics(RLMD) shares are valued at $5.44. The company's market cap stands at 588.91M, with a P/E ratio of -4.89.
On 2026-08-05, Relmada Therapeutics(RLMD) stock moved within a range of $5.33 to $5.54. With shares now at $5.44, the stock is trading +2.1% above its intraday low and -1.8% below the session's peak.
Trading volume for Relmada Therapeutics(RLMD) stock has reached 823.18K, versus its average volume of 1.25M.
Over the past 52 weeks, Relmada Therapeutics(RLMD) stock has traded between a high of $8.00 and a low of $0.55.
Over the past 52 weeks, Relmada Therapeutics(RLMD) stock has traded between a high of $8.00 and a low of $0.55.
Analyst ratings
100%
of 6 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.